Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The certificate was issued by the company's Registrar and Transfer Agent, Kfin Technologies, and submitted separately to both CDSL and NSDL. Kfin confirmed that there were zero dematerialization or rematerialization transactions during the quarter, meaning no shares moved between physical and electronic form. The filing is signed by Rahul Ranjan, Company Secretary, dated January 9, 2026.
This is a standard regulatory compliance filing with no material impact on shareholders or the stock. No business or financial event is being reported — it simply confirms that no share movement between physical and demat form occurred in the quarter.